Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Lung Neoplasms 3Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Neoplasms 1Chronic Pain 1Cancer Pain 1

Interventions

pembrolizumab 88Carboplatin 77Specimen Handling 76Magnetic Resonance Spectroscopy 63Pemetrexed 59Cisplatin 47durvalumab 44Paclitaxel 38Nivolumab 34atezolizumab 32osimertinib 29Radiotherapy 29Radiosurgery 29Biopsy 26Blood Specimen Collection 25Gemcitabine 24Docetaxel 24Immunoglobulin G 23Disulfides 22Standard of Care 21Drug Therapy 21Etoposide 19Taxes 18Practice Guidelines as Topic 18Radiation 17Educational Status 16130-nm albumin-bound paclitaxel 15X-Rays 14Surveys and Questionnaires 14Bevacizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lung Neoplasms × Patient Education as Topic × 1 year × Clear all
NCT06225414 2026-03-30

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

University of California, Irvine

Phase NA Completed
60 enrolled
Thoracic

Lung Neoplasms

NCT06000683 2026-02-20

Empower-LCS

University of California, Irvine

Phase NA Completed
79 enrolled 20 charts
Thoracic

Lung Neoplasms

NCT05747443 2025-12-24

Larch

Kaiser Permanente

Phase NA Active not recruiting
1,837 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡